Trademark: 90711834
Word
TRANSFORMING RADIATION THERAPY
Status Date
Wednesday, May 8, 2024
Filing Date
Friday, May 14, 2021
Published for Opposition
Tuesday, March 15, 2022
5 Pharmaceuticals for reducing side effects or improving efficacy for cancer and oncology patients; pharmaceuticals for the prevention, treatment or management of superoxide mediated conditions; biotechnological preparations for medical use for the treatment of oncological disorders and treatment-related side effects
42 Research and development in the pharmaceutical and biotechnology fields
May 18, 2021
New Application Entered
Feb 8, 2022
Examiners Amendment -Written
Aug 12, 2021
New Application Office Supplied Data Entered
Jan 24, 2022
Assigned To Examiner
Jan 27, 2022
Non-Final Action Written
Jan 27, 2022
Non-Final Action E-Mailed
Jan 27, 2022
Notification Of Non-Final Action E-Mailed
Feb 8, 2022
Examiners Amendment E-Mailed
Feb 8, 2022
Notification Of Examiners Amendment E-Mailed
Feb 8, 2022
Examiner's Amendment Entered
Feb 8, 2022
Approved For Pub - Principal Register
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 15, 2022
Published For Opposition
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
May 10, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 9, 2022
Sou Extension 1 Filed
Nov 9, 2022
Sou Teas Extension Received
Nov 9, 2022
Sou Extension 1 Granted
Nov 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2023
Sou Extension 2 Filed
Apr 24, 2023
Sou Teas Extension Received
Apr 24, 2023
Sou Extension 2 Granted
May 8, 2024
Sou Extension 4 Filed
May 8, 2024
Sou Extension 4 Granted
May 8, 2024
Sou Teas Extension Received
May 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2023
Sou Teas Extension Received
Oct 24, 2023
Sou Extension 3 Filed
Oct 24, 2023
Sou Extension 3 Granted
Trademark Alertz updated from USPTO on 2030-01-24
